24 HRS URINARY MICRO ALBUMIN at Dr. Essa Lab

24 HRS URINARY MICRO ALBUMIN at Dr. Essa Lab

The 24 HRS URINARY MICRO ALBUMIN test at Dr. Essa Lab is a highly specialized, non-invasive laboratory investigation designed to detect minute amounts of the protein albumin in the urine over a continuous 24-hour period. Albumin is a vital protein primarily synthesized by the liver that circulates in the blood, playing a crucial role in maintaining oncotic pressure and transporting hormones, vitamins, and enzymes throughout the body. In healthy individuals, the kidneys’ microscopic filtering units, known as glomeruli, prevent large molecules like albumin from passing into the urine. However, when the glomerular filtration barrier is compromised due to early-stage kidney disease, small amounts of albumin begin to leak through, resulting in a condition known as microalbuminuria.

This diagnostic test is of paramount clinical importance, particularly for individuals living with chronic metabolic and cardiovascular conditions such as diabetes mellitus and hypertension. Because early kidney damage is often entirely asymptomatic, the 24 HRS URINARY MICRO ALBUMIN test serves as an essential early warning system. Detecting microalbuminuria allows healthcare providers to intervene long before significant, irreversible renal impairment or chronic kidney disease (CKD) develops. At Dr. Essa Lab, utilizing state-of-the-art automated clinical chemistry analyzers and highly sensitive immunoturbidimetric assays, we ensure that every specimen is analyzed with the highest degree of precision and clinical accuracy, providing patients and physicians across Pakistan with dependable diagnostic insights.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to ensuring the accuracy of a 24 HRS URINARY MICRO ALBUMIN test, as several physiological factors can temporarily elevate urinary albumin levels, leading to false-positive results. Patients must strictly adhere to the following preparation guidelines:

• Avoid Strenuous Exercise: Refrain from intense physical activity, heavy lifting, or vigorous exercise for at least 24 to 48 hours before starting and during the entire 24-hour collection period, as physical exertion can cause transient albuminuria.
• Maintain Normal Hydration: Drink a normal, healthy amount of water. Avoid excessive fluid intake (over-hydration) or severe dehydration, as extreme fluctuations in urine concentration can affect the test results.
• Medication Review: Inform your prescribing physician about all medications, supplements, and over-the-counter drugs you are taking. Certain medications may influence renal hemodynamics and protein excretion. Do not discontinue prescribed medications unless explicitly instructed by your doctor.
• Infection and Illness: If you are currently experiencing a urinary tract infection (UTI), high fever, or any acute illness, consult your physician before starting the collection, as these conditions can temporarily increase urinary protein levels.
• Menstruation: Female patients should ideally avoid collecting urine during their menstrual period, as contamination with blood can yield inaccurate, falsely elevated albumin readings.

During the Procedure

The 24-hour urine collection process requires meticulous attention to timing and technique. Dr. Essa Lab provides a specialized, clean, preservative-free collection container for this purpose. The step-by-step collection procedure is outlined below:

• Day 1 – Start of Collection: When you first wake up on the morning of the test, urinate into the toilet as usual. Do not collect this first void. Write down the exact time of this void (e.g., 8:00 AM) on the container label. This marks the official start of your 24-hour collection period.
• Subsequent Voids: For the next 24 hours, collect every single drop of urine you pass into the provided container. This includes all daytime voids, any nighttime voids, and the first void of the next morning.
• Day 2 – Final Collection: Exactly 24 hours after your start time (e.g., 8:00 AM on the second day), urinate one final time and add this sample to the collection container. This completes the 24-hour cycle.
• Storage Conditions: Keep the collection container refrigerated or in a cool, dark place throughout the entire 24-hour collection period to prevent bacterial growth and preserve specimen integrity. Do not freeze the sample.
• Submission: Label the container clearly with your full name, registration number, and the exact start and end times of the collection. Deliver the container to your nearest Dr. Essa Lab branch as soon as possible after completing the collection.

When is a 24 HRS URINARY MICRO ALBUMIN Performed?

Diabetic Nephropathy Screening

Diabetic nephropathy is one of the most common and severe microvascular complications of both Type 1 and Type 2 diabetes mellitus. Over time, chronic hyperglycemia damages the delicate endothelial cells and podocytes of the renal glomeruli, leading to progressive kidney damage. The 24 HRS URINARY MICRO ALBUMIN test is performed annually for diabetic patients to detect the earliest signs of glomerular injury. Identifying microalbuminuria at this stage is crucial because it represents a reversible phase of kidney disease where intensive glycemic control and pharmacological interventions can halt or even reverse renal decline.

Hypertensive Kidney Disease Monitoring

Chronic arterial hypertension exerts continuous, high mechanical pressure on the renal vasculature, leading to benign nephrosclerosis and impaired glomerular filtration. Physicians routinely order the 24 HRS URINARY MICRO ALBUMIN test for hypertensive patients to assess whether high blood pressure has begun to affect renal function. The presence of microalbumin in the urine indicates target organ damage, prompting clinicians to optimize antihypertensive therapy, often incorporating medications that offer specific renal protection, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs).

Evaluation of Unexplained Cardiovascular Risk

Microalbuminuria is not only a marker of localized renal damage but also a highly sensitive indicator of systemic endothelial dysfunction and subclinical vascular disease. Patients with elevated urinary albumin excretion rates are at a significantly higher risk for cardiovascular events, including myocardial infarction, stroke, and peripheral arterial disease. Cardiologists and internists frequently utilize this test as a risk stratification tool in patients with metabolic syndrome, dyslipidemia, or a strong family history of premature cardiovascular disease to implement aggressive preventive strategies.

Assessment of Early Renal Dysfunction Symptoms

While early-stage kidney disease is typically silent, some patients may present with subtle clinical signs or risk factors that warrant investigation. Physicians may request a 24 HRS URINARY MICRO ALBUMIN test when evaluating patients who exhibit mild, unexplained edema (particularly around the eyes, ankles, or feet), persistent fatigue, or fluctuating blood pressure readings. By evaluating the total albumin excretion over 24 hours, clinicians can differentiate between transient physiological variations and persistent, pathological renal dysfunction.

Monitoring Therapeutic Efficacy in Chronic Kidney Disease

For patients who have already been diagnosed with early-stage chronic kidney disease or microalbuminuria, the 24 HRS URINARY MICRO ALBUMIN test is performed periodically to monitor the effectiveness of therapeutic interventions. A stable or declining level of urinary albumin indicates that the patient’s treatment regimen—comprising blood pressure control, blood glucose management, dietary modifications, and nephroprotective medications—is successfully mitigating glomerular stress and preserving remaining kidney function.

What Does a 24 HRS URINARY MICRO ALBUMIN Detect?

The 24 HRS URINARY MICRO ALBUMIN test is a highly sensitive diagnostic tool that can detect a wide range of physiological, pathological, and clinical states related to renal health and systemic vascular integrity. Specifically, this test detects and helps evaluate:

• Normal Albumin Excretion: Urinary albumin levels within the physiological reference range (typically less than 30 mg per 24 hours), indicating healthy glomerular filtration.
• Early Microalbuminuria: Persistent albumin excretion between 30 and 300 mg per 24 hours, signaling early-stage glomerular damage and endothelial dysfunction.
• Macroalbuminuria (Clinical Proteinuria): Albumin levels exceeding 300 mg per 24 hours, indicating advanced glomerular injury and a higher risk of progression to end-stage renal disease (ESRD).
• Diabetic Nephropathy Progression: The onset and advancement of diabetic kidney disease in patients with Type 1 or Type 2 diabetes.
• Hypertensive Nephrosclerosis: Renal vascular damage resulting from chronic, poorly controlled arterial hypertension.
• Endothelial Dysfunction: Systemic vascular damage and increased permeability of blood vessels, which correlates with heightened cardiovascular risk.
• Preeclampsia Risk: Early signs of renal involvement in pregnant women, helping obstetricians monitor for hypertensive disorders of pregnancy.
• Glomerulonephritis: Early inflammatory processes affecting the renal glomeruli before macroproteinuria becomes evident.
• Orthostatic Proteinuria: A benign condition where protein is excreted primarily when the patient is in an upright position, distinguished by comparative clinical evaluation.
• Exercise-Induced Albuminuria: Transient, non-pathological elevations in urinary albumin caused by recent intense physical exertion.
• Fever-Induced Proteinuria: Temporary increases in glomerular permeability associated with high body temperature or acute systemic infections.
• Urinary Tract Infection (UTI) Interference: Falsely elevated albumin levels caused by localized inflammation and protein release within the urinary tract.
• Cardiovascular Disease Risk: Subclinical vascular changes that serve as an independent predictor of adverse cardiac events.
• Response to Nephroprotective Therapy: The therapeutic success of ACE inhibitors, ARBs, or SGLT2 inhibitors in reducing urinary protein leakage.
• Early Renal Graft Rejection: Subclinical changes in renal function and glomerular integrity in kidney transplant recipients.
• Lupus Nephritis: Early renal involvement in patients diagnosed with systemic lupus erythematosus (SLE).
• Amyloidosis: Early deposition of abnormal proteins in the kidneys, disrupting the glomerular basement membrane.
• Obesity-Related Glomerulopathy: Glomerular hyperfiltration and injury associated with severe obesity and metabolic syndrome.
• Drug-Induced Nephrotoxicity: Early signs of kidney irritation or damage resulting from nephrotoxic medications or contrast agents.
• Subclinical Renal Vasculitis: Inflammation of the small blood vessels within the kidneys, leading to micro-leakage of proteins.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The 24 HRS URINARY MICRO ALBUMIN test is processed using advanced, high-throughput automated chemistry analyzers that undergo rigorous daily quality control protocols. Typically, the verified test report is available within 24 to 48 hours after the complete 24-hour urine specimen is received at our laboratory.

Patients can access their diagnostic reports conveniently through multiple channels. Dr. Essa Lab offers an intuitive online patient portal on our official website, where reports can be viewed, downloaded, and printed securely using the unique patient ID and password provided on the booking receipt. Additionally, patients receive real-time SMS notifications once their reports are finalized, containing a direct link to download the PDF report. Physical copies of the report can also be collected from any of our conveniently located diagnostic centers across Karachi and other major cities.

24 HRS URINARY MICRO ALBUMIN Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Albumin Excretion Rate (AER)	< 30 mg / 24 hours	30 – 300 mg / 24 hours (Microalbuminuria); > 300 mg / 24 hours (Macroalbuminuria)
Total Urine Volume	800 – 2000 mL / 24 hours (varies with fluid intake)	< 400 mL / 24 hours (Oliguria); > 2500 mL / 24 hours (Polyuria)
Urine Creatinine (if co-ordered)	0.5 – 2.15 g / 24 hours (dependent on muscle mass)	Decreased levels in severe renal impairment, muscle wasting diseases, or incomplete collection
Albumin-to-Creatinine Ratio (ACR equivalent)	< 30 mg/g (or < 3 mg/mmol)	30 – 300 mg/g (Early renal damage); > 300 mg/g (Severe renal damage)
Specimen Appearance	Clear to light yellow	Turbid/Cloudy (Infection, crystals); Dark/Tea-colored (Hematuria, bilirubinuria)
Urine pH	4.6 – 8.0 (typically around 6.0)	Highly alkaline pH (UTI, renal tubular acidosis); Highly acidic pH (Diabetic ketoacidosis, starvation)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for 24 HRS URINARY MICRO ALBUMIN?

• Experienced Healthcare Professionals: Our laboratory is directed by highly qualified consultant pathologists and clinical biochemists who oversee all testing procedures.
• Patient-Focused Care: We prioritize patient comfort, clear communication, and compassionate service at every stage of the diagnostic journey.
• Quality Diagnostic Services: Dr. Essa Lab maintains strict internal and external quality control standards, ensuring international-grade diagnostic accuracy.
• Professional Reporting: Our reports are structured, comprehensive, and easy for both patients and referring physicians to interpret.
• Modern Diagnostic Approach: We utilize state-of-the-art automated immunoassay and clinical chemistry platforms to minimize human error.
• Comfortable Environment: All our collection centers are designed to provide a clean, hygienic, and welcoming experience for patients.
• Convenient Location: With an extensive network of branches across Karachi and beyond, accessing our diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built a multi-decadal legacy of trust, precision, and dedication to public health.